Marker Therapeutics Inc
NASDAQ:MRKR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Marker Therapeutics Inc
NASDAQ:MRKR
|
US |
|
Korian SA
F:KO2
|
FR |
|
Uniti Group Inc
NASDAQ:UNIT
|
US |
|
Agronomics Ltd
LSE:ANIC
|
IM |
|
D
|
Diginex Ltd
NASDAQ:DGNX
|
HK |
|
George Weston Ltd
TSX:WN
|
CA |
|
NobleOak Life Ltd
ASX:NOL
|
AU |
|
D
|
Directa SIM SpA
F:ZP7
|
IT |
|
Elanor Investors Group
ASX:ENN
|
AU |
|
Badger Infrastructure Solutions Ltd
TSX:BDGI
|
CA |
|
W
|
Wha Utilities and Power PCL
SET:WHAUP
|
TH |
|
Stoneweg Europe Stapled Trust
SGX:SET
|
SG |
|
Palantir Technologies Inc
NASDAQ:PLTR
|
US |
Wall Street
Price Targets
MRKR Price Targets Summary
Marker Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
MRKR
is 9.21 USD
with a low forecast of 5.66 USD and a high forecast of 13.13 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MRKR's stock price target?
Price Target
9.21
USD
According to Wall Street analysts, the average 1-year price target for
MRKR
is 9.21 USD
with a low forecast of 5.66 USD and a high forecast of 13.13 USD.
What is Marker Therapeutics Inc's Revenue forecast?
Projected CAGR
109%
The
compound annual growth rate
of Marker Therapeutics Inc's revenue for the next 4 years is
109%.
